Glioblastoma produces a wide range of symptoms, and no two patients experience exactly the same combination. The most common early signs include personality changes, headaches, seizures, cognitive difficulties, and progressive weakness on one side of the body. What makes glioblastoma symptoms particularly tricky is that many of them mimic other, far more common conditions, and the specific symptoms a person develops depend heavily on where in the brain the tumor grows.
Personality and Behavioral Changes Often Come First
One of the most striking and underappreciated features of glioblastoma is how often personality change is the very first symptom. In an Australian study of initial presentations, personality change was the single most common presenting symptom, occurring in about 23% of patients, and over half of all patients first showed up at the emergency department rather than through a routine referral.1PubMed. Nature and impact of symptoms at time of initial presentation for patients with glioblastoma That statistic surprises people who expect a brain tumor to announce itself with headaches or seizures. Instead, a family member might notice that their loved one has become unusually irritable, apathetic, impulsive, or emotionally flat weeks or months before any other neurological sign appears.
A systematic review of personality and behavioral changes in glioma patients found reported prevalence rates ranging from 8% to 67%, with the wide spread reflecting differences in how “personality change” was defined and measured across studies.2PubMed Central. Prevalence of changes in personality and behavior in adult glioma patients: a systematic review In a case series of patients with tumors growing in both hemispheres, personality change was essentially universal. These changes were linked to significant distress and reduced quality of life for both patients and their caregivers. Among patients with newly diagnosed glioblastoma specifically, roughly a third reported clinically meaningful executive dysfunction, about a quarter reported significant apathy, and around a fifth showed notable disinhibition after disease onset.3Neuro-Oncology Practice. Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma
This matters practically because these changes are easy to misattribute to depression, stress, aging, or relationship problems. Families sometimes spend months consulting psychiatrists or marriage counselors before a neurological cause is even considered, especially when the patient themselves does not recognize the change.
Where the Tumor Sits Shapes What You Feel
The brain is not a uniform organ. Different regions handle different functions, and glioblastoma has a preference for certain neighborhoods. The frontal and temporal lobes are the most frequently involved areas.4PubMed Central. Association between the Anatomical Location of Glioblastoma and Its Evaluation with Clinical Considerations: A Systematic Review and Meta-Analysis That matters because frontal lobe tumors tend to produce mood and behavioral symptoms, while temporal lobe tumors are more closely linked to memory problems, language difficulties, and seizures. A tumor in the occipital lobe at the back of the head is more likely to cause visual disturbances, while one near the motor cortex can produce progressive weakness or coordination problems on the opposite side of the body.
Research using brain-mapping techniques has also shown that glioblastomas located around certain left-hemisphere structures, including the area near the upper part of the left lateral ventricle, the left thalamus, and the left caudate nucleus, are associated with reduced cognitive function from the patient’s own perspective before surgery even takes place.5PubMed Central. Association between patient-reported cognitive function and location of glioblastoma The left hemisphere dominates language and analytical processing in most people, so tumors on that side tend to produce more noticeable cognitive complaints.
This location-dependence is one reason glioblastoma gets misdiagnosed. A frontal tumor causing apathy and poor judgment looks psychiatric. A temporal tumor causing word-finding trouble can be mistaken for early dementia. Only when the full picture is assembled, or when imaging is finally ordered, does the diagnosis become clear.
Cognitive Decline Before Treatment Even Begins
Cognitive problems in glioblastoma are not mainly a side effect of chemotherapy or radiation. Up to 90% of glioblastoma patients already show cognitive decline before any treatment starts.6PubMed Central. Cognitive Decline in GB Patients with Different Treatment Modalities and Insights on Untreated Cases Attention, memory, and organizational skills are typically the hardest hit. The tumor itself disrupts normal neural circuits both by physically displacing brain tissue and by altering the chemical environment around it.
Before their diagnosis, only about 6% of newly diagnosed glioblastoma patients reported having clinically significant neurobehavioral symptoms. After disease onset but before treatment began, that figure jumped to 26%.7Neuro-Oncology Practice. Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma The speed of this decline varies, but it can unfold over just weeks. Some patients describe it as a feeling of mental fog, difficulty following conversations, or forgetting things they would normally remember easily.
Headaches and Swelling
Headaches are the symptom most commonly associated with brain tumors in the public imagination, yet they are not always the first or most prominent symptom of glioblastoma. When they do occur, glioblastoma headaches tend to differ from ordinary tension headaches or migraines: they are often worse in the morning, may intensify with coughing or straining, and can progressively worsen over days to weeks rather than coming and going.
The mechanism behind these headaches involves both physical pressure and chemical signaling. The tumor and its surrounding swelling pull on pain-sensitive structures like the meninges and blood vessels, while increased pressure inside the skull adds to the problem. There is also evidence of peripheral sensitization and neurogenic inflammation involving the nerve fibers that line the meninges and cranial blood vessels.8PubMed. Mechanism of brain tumor headache
Much of the symptom burden in glioblastoma comes not from the tumor mass alone but from the swelling around it, known as peritumoral edema. This swelling results from plasma leaking through damaged blood vessels into the surrounding brain tissue, and the area of swelling often exceeds the size of the tumor itself.9PubMed. Critical Care Management of Cerebral Edema in Brain Tumors This edema can cause severe neurological dysfunction and, in extreme cases, dangerous shifts in brain tissue.10PubMed Central. Peritumoral Edema in Gliomas: A Review of Mechanisms and Management The practical consequence is that a patient’s symptoms can fluctuate dramatically: when the swelling increases, symptoms worsen, and when steroids bring it down, symptoms may temporarily improve.
Seizures as a Presenting Sign
Seizures are one of the more alarming ways glioblastoma can reveal itself. They can range from full convulsive episodes to subtler events like a strange smell, a brief moment of confusion, or involuntary twitching of one limb. The seizure activity is driven by multiple factors: the tumor disrupts normal neural connections, alters the chemical environment, causes local swelling and inflammation, and releases metabolically active molecules that make the surrounding brain tissue abnormally excitable.11PubMed. Brain tumors and epilepsy: pathophysiology of peritumoral changes
Tumor location matters here too. Tumors near the cortical surface, especially in the temporal lobe, are more seizure-prone than deep-seated tumors. A first-time seizure in an adult, particularly someone over 40 with no prior history of epilepsy, is always taken seriously as a possible sign of a structural brain lesion and typically prompts brain imaging. For some patients, a seizure turns out to be the event that leads to their glioblastoma diagnosis, which can paradoxically be somewhat fortunate if it leads to earlier detection than would have occurred with slower-progressing symptoms like personality change.
Vision and Language Problems
Visual symptoms in glioblastoma depend on whether and how the tumor affects the visual pathways. When a glioblastoma grows near or into the occipital lobe or along the optic radiation, patients can develop blind spots in specific parts of their visual field. These deficits are sometimes subtle enough that the patient does not notice them in daily life. In some cases, formal visual field testing has picked up tumor progression months before standard brain imaging showed any change, suggesting that the visual pathways can be among the earliest structures to register tumor growth.12PubMed Central. Visual field changes as an early indicator of glioblastoma multiforme progression: two cases of functional vision changes before MRI detection More aggressive presentations can cause rapid and severe vision loss over a matter of weeks.13PubMed Central. Rapid Vision Loss Due to Multifocal Glioma: A Diagnostic Challenge
Language disruption, or aphasia, affects roughly a quarter of brain tumor patients overall.14PubMed Central. Characteristics, Diagnosis, and Treatment of Aphasia in Patients With Brain Tumors: A Scoping Review This can show up as difficulty finding words, trouble forming grammatically correct sentences, or problems understanding what others say. One complicating factor is that standard assessments designed for stroke patients tend to underestimate the severity of tumor-related aphasia. In one review, stroke-based tools detected aphasia in only about 27% of affected patients, while broader neuropsychological testing caught it in 77%. The language deficits caused by a slowly growing tumor are often more diffuse and harder to categorize neatly than those caused by a sudden stroke.
Fatigue, Sleep Problems, and Depression
Fatigue is one of the most common and most debilitating symptoms of glioblastoma, and like cognitive decline, it is present well before treatment starts. A prospective study found that 48% of glioblastoma patients had clinically significant fatigue at baseline, compared with just 11% of healthy controls.15Neuro-Oncology. Prevalence and predictors of fatigue in glioblastoma: a prospective study Depression, left-sided tumor location, and female sex were the strongest predictors of fatigue severity. Sleep disturbance is also common: about 70% of newly diagnosed patients scored above the clinical cutoff for sleep problems.16Neuro-Oncology Practice. Neurocognitive impairment, neurobehavioral symptoms, fatigue, sleep disturbance, and depressive symptoms in patients with newly diagnosed glioblastoma
The cause of this fatigue appears to be multifactorial, involving biological processes like inflammatory signaling as well as behavioral and psychological factors.17PubMed Central. Fatigue among patients with brain tumors This is not ordinary tiredness. Patients describe it as a bone-deep exhaustion that rest does not relieve, and it can be severe enough to interfere with basic daily activities even when other neurological symptoms are relatively mild. Depression compounds the picture. About 16% of newly diagnosed glioblastoma patients meet clinical cutoffs for depressive symptoms, and distinguishing between depression caused by the disease process itself and depression as a psychological reaction to the diagnosis is not straightforward.
When Glioblastoma Mimics a Stroke
One of the more dangerous diagnostic pitfalls with glioblastoma is that it can mimic a stroke. A patient who arrives at the emergency department with sudden weakness on one side, speech difficulty, or confusion may initially be treated as a stroke case. In a Japanese study of over 200 glioma patients, roughly 6% had imaging findings that were confused with stroke.18PubMed Central. Stroke Mimics and Chameleons from the Radiological Viewpoint of Glioma Diagnosis When a glioma presented on imaging in a way that looked like a stroke, the delay to correct diagnosis was substantial, with a median of over 60 days in the cases classified as stroke mimics. Three of the eight stroke mimic cases in that study turned out to be glioblastoma.
The reverse also happens: glioblastoma can bleed internally, and the resulting hemorrhage looks and acts exactly like a stroke. In a study of patients who experienced sudden bleeding into their gliomas, over 70% turned out to have the highest-grade tumors. Patients who arrived in poor neurological condition had high perioperative mortality.19PubMed Central. Clinical features and treatment of apoplectic intratumoral hemorrhage of glioma These acute presentations are a reminder that glioblastoma is not always a gradual disease; it can produce medical emergencies with little warning.
Steroids and Symptom Management
Because so many glioblastoma symptoms are driven by swelling rather than the tumor mass itself, corticosteroids are a cornerstone of symptom management. Dexamethasone is the most commonly used steroid for this purpose and is recommended for relieving symptoms related to cerebral edema in high-grade glioma patients.20PubMed Central. Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline The effect can be dramatic: a patient with worsening headache, confusion, or weakness may improve substantially within 24 to 48 hours of starting steroids.
The tradeoff is that steroids carry their own significant side effects, including muscle weakness, weight gain, elevated blood sugar, bone thinning, mood swings, insomnia, and increased vulnerability to infection. The longer they are used and the higher the dose, the worse these side effects become. Clinicians try to use the lowest effective dose for the shortest possible time, but many glioblastoma patients end up on steroids for extended periods because their symptoms return whenever the dose is reduced.
Distinguishing between symptoms caused by the tumor, symptoms caused by treatment, and symptoms caused by steroids can be genuinely difficult for patients and their families. Radiation treatment adds another layer: radiation necrosis, a form of tissue damage caused by the treatment itself, can look almost identical to tumor progression on brain imaging, with both producing ring-enhancing lesions.21PubMed Central. Differentiation Between Radiation Necrosis and True Tumour Progression After Radiotherapy to Intracranial Metastases Specific imaging features can help tell them apart, but even experienced neuroradiologists sometimes cannot be certain without a biopsy.
When the Patient Cannot Tell You What Is Wrong
An especially challenging aspect of glioblastoma is that the disease can impair a person’s ability to recognize their own symptoms, a phenomenon called anosognosia. A patient with a frontal lobe tumor causing significant behavioral change may genuinely not perceive any difference in themselves. Research comparing patient self-reports to caregiver assessments in glioma patients has found that patients tend to rate their own physical function and general health as better than their caregivers do.22PubMed Central. Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients The gap between patient and caregiver ratings is larger in patients with measurable cognitive impairment.
This has real consequences for care. If a patient does not recognize their own cognitive or behavioral decline, they may resist medical evaluation, insist on driving when it is no longer safe, or refuse to acknowledge the need for help at home. Caregivers often become the primary source of clinical information, and their observations about personality shifts, memory lapses, or functional decline can be more accurate than the patient’s own account. If you are a family member noticing changes in a loved one that they dismiss or seem unaware of, that disconnect itself can be a meaningful neurological sign worth reporting to their medical team.
How Symptoms Evolve Toward the End of Life
The symptom landscape of glioblastoma shifts as the disease progresses. A prospective study that tracked 50 patients with high-grade glioma through their final weeks found that the most severe symptoms during the last two weeks of life were drowsiness, difficulty concentrating, fatigue, difficulty speaking, weakness, and difficulty understanding.23PubMed Central. Prospective assessment of end-of-life symptoms and quality of life in patients with high-grade glioma Nearly all symptoms worsened significantly as death approached, with two exceptions: weakness and memory impairment, which were already severe at baseline and did not have much room to deteriorate further. Seizures, somewhat counterintuitively, were rare in the final weeks and did not progressively worsen.
The most practically important finding from that study was about decision-making capacity. The composite score measuring patients’ ability to participate in decisions roughly doubled during the end-of-life phase, meaning decision-making capacity declined dramatically. This underscores the importance of having advance care planning conversations early in the disease course, while patients can still articulate their preferences. Families who wait until symptoms are severe often find that the patient is no longer able to participate meaningfully in those discussions.
Why Glioblastoma Symptoms Are So Often Attributed to Something Else
Glioblastoma is rare, affecting a few people per hundred thousand each year, while every one of its individual symptoms is common in the general population. Headaches, fatigue, mood changes, forgetfulness, and irritability all have mundane explanations that are correct the vast majority of the time. No reasonable clinician orders a brain MRI for every patient who feels tired or forgetful. The result is that glioblastoma often develops through a period of weeks to months where symptoms are present but plausibly attributed to stress, poor sleep, depression, or simply getting older.
The combination of symptoms and their progression is what eventually tips the balance. A headache that is steadily worsening over weeks, paired with new personality changes or a subtle weakness on one side, is a different clinical picture from a headache alone. Language problems developing alongside new seizure-like episodes, or cognitive decline accelerating over weeks rather than months, should prompt imaging. There is no blood test for glioblastoma and no screening protocol for average-risk people. The diagnosis depends on someone, whether the patient, a family member, or a clinician, recognizing that the pattern of symptoms does not fit the usual explanations and pushing for a brain scan.